Skip to content
Governance Register

← US public companies

Harpoon Therapeutics, Inc.

SEC CIK 1708493 · HARP · last insider filing 2024-03-11

Directors (from insider filings)

NameCapacity as filedFilings
Bailes Joseph S Director filed 2020 - 2024
Silvernail Lauren P Director filed 2022 - 2024
Hunt Ronald Director filed 2019 - 2024
Lathi Vijay K Director filed 2023 - 2024
Myers Scott Dunseth Director filed 2019 - 2024
Eastland Julia Marie Director · President and CEO filed 2019 - 2024
Drachman Jonathan G Director filed 2019 - 2024
Robbins Andrews R Director filed 2020 - 2024
New Leaf Ventures III, L.P. Director filed 2019 - 2024
New Leaf Venture Associates III, L.P. Director filed 2019 - 2024
New Leaf Venture Management III, L.L.C. Director filed 2019 - 2024
Chin Mark Director filed 2019 - 2024
New Leaf Biopharma Opportunities II, L.P. Director filed 2019 - 2024
New Leaf BPO Management II, L.L.C Director filed 2019 - 2024
New Leaf BPO Associates II, L.P. Director filed 2019 - 2024
Colowick Alan Director filed 2021 - 2023
Viney Joanne L. Director filed 2020 - 2023
Evnin Luke Director filed 2019 - 2021
Mcmahon Gerald PhD Director · President and CEO filed 2019 - 2021
Baeuerle Patrick Director filed 2019 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Lanza Frank J Principal Fin. & Acctng Ofc. filed 2022 - 2024
Bucher James B Chief Legal Officer filed 2023 - 2024
Walker Luke Nathaniel Chief Medical Officer filed 2022 - 2024
Erbez Georgia Chief Financial Officer filed 2019 - 2022
Sacks Natalie Chief Medical Officer filed 2019 - 2022
Wesche Holger Chief Scientific Officer filed 2019 - 2022

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.